Focusing on malaria drug discovery

MMV guest edits a special focus issue on malaria drug discovery in Future Medicinal Chemistry

13 Dec 2012

The December issue of Future Medicinal Chemistry will be dedicated to antimalarial drug discovery and guest edited by Jeremy Burrows, MMV’s Head of Discovery.

“Interest in malaria drug research has undergone radical renewal in the past decade,” said Jeremy. “The disease places an unacceptably huge burden on vulnerable populations around the world. It is clear that new tools to control and eliminate this fatal disease are urgently needed. This issue of Future Medicinal Chemistry reflects this urgency and brings to light a broad spectrum of exciting research focused on malaria.”

The issue includes numerous contributions from leading experts around the world who reveal the latest thinking, from target-based drug discovery through to high-throughput screening of the whole cell. Contributors also explain the growing appreciation that malaria eradication will require novel and innovative interventions to block transmission of the parasite and radically cure relapsing malaria.

“The Malaria Eradication Agenda challenge is … tough,” continued Jeremy. “And so it’s reassuring to know that researchers and drug developers are at their innovative best in malaria drug research, seeking drugs that not only cure, but also block transmission and counter resistance.”

All articles from this issue will be free to access until the end of March 2013 from the journal’s website.